Implementing the 340B Insulin/Epi-Pen EO in Your Health Center | Webinar

Implementing the 340B Insulin / Epi-Pen Executive Order In Your Health Center

On April 15, 2025, President Trump issued an Executive Order addressing issues relating to high drug prices. One section of the Executive Order requires Section 330(e) grantees to make insulin and injectable epinephrine (“Epi-Pens”) available at or below the 340B price to low-income individuals with a high cost-sharing requirements, high unmet deductible, or no healthcare insurance. Though guidance on implementing the Executive Order is scarce, a similar order issued in the first Trump Administration provides significant clues as to how HHS will interpret the order.

This webinar discusses what we know and what we do not and discusses how health centers should aim to comply with the requirements.

Presenters:

• Jason Reddish
• Joella Roland